Navigenics

edit

Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics’ lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.

Milestones

edit

• 
  Navigenics received $25M in Unattributed funding. (11/7/07)
  Posted 6/18/09 at 4:12pm

Videos

Screenshots

edit

Sources

1. Navigenics raises more than $25M for personal genetics (deals.venturebeat.com) [edit]